Novoprotein reported a net loss of 54.8068 million yuan for the fiscal year 2024
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Novoprotein released its 2024 annual performance preliminary report, stating that the total operating revenue for 2024 was 127 million yuan, a year-on-year decrease of 16.81%; the net loss attributable to the parent company's owners was 54.8068 million yuan; the net loss attributable to the parent company's owners after deducting non-recurring gains and losses was 72.2141 million yuan; the basic loss per share was 0.78 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments